Dermapharm Holding SE

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A2GS5D8
EUR
46.75
0.55 (1.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,164.98
1,180.77
1,135.35
1,024.78
942.91
793.83
700.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,164.98
1,180.77
1,135.35
1,024.78
942.91
793.83
700.88
Raw Material Cost
773.27
790.67
792.49
654.54
545.53
540.42
486.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
292.88
281.11
265.74
185.43
165.99
159.28
117.13
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
52.66
63.39
59.55
13.87
9.85
10.61
10.89
Selling and Distribution Expenses
158.79
171.18
131.89
96.17
112.62
95.65
88.35
Other Expenses
-33.44
-33.30
-31.47
-18.61
-16.17
-15.72
-11.68
Total Expenditure (Excl Depreciation)
943.23
973.38
935.00
763.89
672.32
648.73
586.24
Operating Profit (PBDIT) excl Other Income
221.70000000000002
207.39999999999998
200.3
260.9
270.59999999999997
145.1
114.60000000000001
Other Income
11.54
24.70
18.72
10.76
20.48
3.12
4.63
Operating Profit (PBDIT)
325.85
322.58
323.66
372.82
354.48
200.94
170.88
Interest
52.66
63.39
59.55
13.87
9.85
10.61
10.89
Exceptional Items
-1.46
1.79
-46.36
-27.94
3.62
-14.38
1.32
Gross Profit (PBDT)
391.71
390.10
342.86
370.23
397.38
253.41
214.20
Depreciation
92.56
90.50
104.59
101.18
55.60
49.17
50.12
Profit Before Tax
179.17
170.49
113.16
229.84
292.65
126.79
111.18
Tax
52.16
60.27
45.46
83.68
84.07
39.36
32.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
132.41
113.79
62.37
134.24
209.58
85.83
77.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
132.41
113.79
62.37
134.24
209.58
85.83
77.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.06
-2.05
-1.83
-1.62
-0.68
0.10
0.62
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
131.35
111.74
60.53
132.62
208.90
85.93
77.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
694.38
604.42
539.21
531.59
497.32
321.97
278.65
Earnings per share (EPS)
2.46
2.11
1.16
2.49
3.89
1.59
1.43
Diluted Earnings per share
2.46
2.11
1.16
2.49
3.89
1.59
1.43
Operating Profit Margin (Excl OI)
19.03%
17.56%
17.65%
25.46%
29.53%
18.73%
16.57%
Gross Profit Margin
23.32%
22.1%
19.18%
32.3%
36.93%
22.17%
23.01%
PAT Margin
11.37%
9.64%
5.49%
13.1%
22.23%
10.81%
11.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -1.34% vs 4.00% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 17.64% vs 84.63% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 5.51% vs -2.30% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -16.88% vs 6.55% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Dermapharm Holding SE With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
1,164.98
788.37
376.61
47.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,164.98
788.37
376.61
47.77%
Raw Material Cost
773.27
723.14
50.13
6.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
292.88
456.54
-163.66
-35.85%
Power Cost
0
0
0.00
Manufacturing Expenses
52.66
14.44
38.22
264.68%
Selling and Distribution Expenses
158.79
128.73
30.06
23.35%
Other Expenses
-33.44
-39.36
5.92
15.04%
Total Expenditure (Excl Depreciation)
943.23
929.25
13.98
1.50%
Operating Profit (PBDIT) excl Other Income
221.75
-140.87
362.62
257.41%
Other Income
11.54
29.33
-17.79
-60.65%
Operating Profit (PBDIT)
325.85
-12.07
337.92
2,799.67%
Interest
52.66
14.44
38.22
264.68%
Exceptional Items
-1.46
-1.31
-0.15
-11.45%
Gross Profit (PBDT)
391.71
65.24
326.47
500.41%
Depreciation
92.56
99.48
-6.92
-6.96%
Profit Before Tax
179.17
-127.30
306.47
240.75%
Tax
52.16
-24.86
77.02
309.81%
Provisions and contingencies
0
0
0.00
Profit After Tax
132.41
-103.52
235.93
227.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
132.41
-103.52
235.93
227.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.06
0.00
-1.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
131.35
-103.52
234.87
226.88%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
694.38
813.70
-119.32
-14.66%
Earnings per share (EPS)
2.46
-0.58
3.04
524.14%
Diluted Earnings per share
2.46
-0.58
3.04
524.14%
Operating Profit Margin (Excl OI)
19.03%
-17.87%
0.00
36.90%
Gross Profit Margin
23.32%
-3.53%
0.00
26.85%
PAT Margin
11.37%
-13.13%
0.00
24.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 116.50 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -1.34% vs 4.00% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 13.14 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 17.64% vs 84.63% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.43 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 5.51% vs -2.30% in Dec 2024

Annual - Interest
Interest 5.27 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -16.88% vs 6.55% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.03%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024